Keyword: WIRB-Copernicus Group
WIRB-Copernicus Group has added two new executives to its roster as it expands its Global Research Network of investigative sites.
WIRB-Copernicus launched a product aimed at upping the efficiency of clinical research operators at institutions and independent research sites.
WIRB-Copernicus Group acquires Velos eResearch, a clinical trial management solutions provider, for an undisclosed price.
Clinical research helper WIRB-Copernicus Group has acquired KMR Group and Metrics Consortium to bolster its market insights and intelligence division.
UCSF scientist Shaun Coughlin will lead CV research at NIBR, Novo's China GM was promoted to EVP, and Cavion poached Teva exec to head up R&D.
WIRB-Copernicus Group has bought Patient Genesis’ eConsent technology, ConsentNow.
Scott Gottlieb was confirmed to lead FDA, neuroscientist Thomas Insel left Verily, Immunomedics' CEO and CSO stepped down.
WIRB-Copernicus Group continued an acquisition spree with purchases of electronic clinical outcome assessments specialists MedAvante and ProPhase.